# Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

> **NCT01917877** · PHASE2 · UNKNOWN · sponsor: **Qingdao Central Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01917877
- **Lead sponsor:** Qingdao Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917877, "Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01917877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*